Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for prolonged isolated thrombocytopenia after allo-HSCT
NCT03391856Phase 3Terminated
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Thrombocytopenia, sponsored by Peking University People's Hospital. Started Mar 2018; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03391856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391856.